Stockhub

Biotron Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 August 2022

  • curprev 07:0307:03, 23 August 2022 >Nick 500 bytes +500 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. == References and notes == Ca..."
Retrieved from "https://stockhub.co/research/Biotron_Limited"